⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 1, 1993Journal of Clinical Oncology

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

David Cella David S. Tulsky Geoffrey V. Gray Bernie Sarafian Eric Linn Amy E. Bonomi M Silberman S B Yellen Patsy Winicour J Brannon

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to develop and validate a scale that measures quality of life in cancer patients.
Developed the FACT-G scale for quality of life assessment in oncology.
Conducted validation studies to ensure reliability and responsiveness in clinical settings.
Evaluated ease of administration and brevity for practical use in clinical trials.
FACT-G fulfills all necessary criteria for use in oncology trials.
Demonstrated strong reliability and validity for assessing quality of life.
Responded effectively to clinical changes in patient populations.

Implication

Validates the FACT-G measure in oncology, indicating its effectiveness for assessing quality of life.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cella et al. (1993) studied this question.

synapsesocial.com/papers/69d85126d2f7327e70ae2f54 https://doi.org/10.1200/jco.1993.11.3.570

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Psychometric properties of the Functional Assessment of Cancer Therapy–Lung (FACT-L) scale to measure health-related quality of lifeOriginal Research · 2026
2Assessing content validity of the functional assessment of cancer therapy–cutaneous T-cell lymphoma (FACT-CTCL): a qualitative studyOriginal Research · 2026
3The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments2024 · 8 citations
4Measuring Health-Related Quality of Life in Patients With Hepatobiliary Cancers: The Functional Assessment of Cancer Therapy–Hepatobiliary QuestionnaireOriginal Research · 2002 · 279 citations
5International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12)Late-Phase Clinical Trial · 2016 · 182 citations

More related papers

Quality of life in patients with primary and metastatic brain tumors in the literature as assessed by the FACT-Br2012
Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients2022
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer – an updated literature review2026

More from Journal of Clinical Oncology

Association of Circulating Eosinophils With Systemic Immune Activation and Reduced Recurrence in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast CancerTue,
Hypofractionated Versus Conventionally Fractionated Postmastectomy Radiotherapy With Internal Mammary Node Irradiation for High-Risk Breast Cancer (HypoMast-IMNI): A Randomized Phase III TrialMon,